By Tony Fong

NEW YORK (GenomeWeb News) – The number of mergers and acquisitions in the life science 'omics tools and molecular diagnostics space rose 15 percent year over year for the first half of 2011, spurred on by the low cost of debt and a handful of companies that proved to be especially aggressive buyers.

Despite the uptick, though, the M&A environment remains mixed and the forecast for the near future is unclear, according to industry observers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: human cytomegalovirus diversity, patterns of homologous recombination in E. coli, and more.

US lawmakers are considering eliminating the medical devices tax that is part of the Affordable Care Act.

Two research teams in China home in on a gene that gives rice a long, slender shape.

Marcia McNutt, the editor-in-chief of Science, has been nominated to become president of the US National Academy of Sciences.

Jul
14
Sponsored by
Agilent Technologies

This online seminar will outline a recent example of the use of molecular barcoding in combination with next-generation sequencing to detect somatic mosaicism in cancer patients.